Tokyo, Japan

Kazuhiko Osoda

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Astellas Pharma Gmbh. Active years: 2011-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuhiko Osoda. Retrieved from https://idiyas.com/inventor/kazuhiko-osoda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

 

 

Average Co-Inventor Count = 13.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2011-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kazuhiko Osoda: Innovator in Pharmaceutical Chemistry

Introduction

Kazuhiko Osoda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the human body. With a total of 2 patents, his work has the potential to impact the treatment of various medical conditions.

Latest Patents

Osoda's latest patents include a piperazine derivative designed to act as an MCreceptor agonist. This compound has been shown to have an action related to MCreceptor agonists, making it a promising candidate for preventing or treating bladder and urinary tract diseases. These conditions include underactive bladder, hypotonic bladder, acontractile bladder, detrusor underactivity, neurogenic bladder, urethral relaxation failure, detrusor-external urethral sphincter dyssynergia, and voiding dysfunctions associated with benign prostatic hyperplasia.

Another significant patent involves a propane-1,3-dione derivative or its salt, which serves as a GnRH receptor antagonist. This compound has demonstrated a potent GnRH receptor antagonistic effect, making it useful for treating sex hormone-dependent diseases, particularly those related to GnRH. The compound also exhibits excellent metabolic stability in humans and minimal drug interactions, enhancing its potential as a pharmaceutical agent.

Career Highlights

Kazuhiko Osoda is currently associated with Astellas Pharma GmbH, where he continues to innovate in the field of drug development. His work focuses on creating effective treatments for complex medical conditions, showcasing his dedication to improving patient outcomes.

Collaborations

Osoda has collaborated with notable colleagues, including Masaaki Hirano and Isao Kinoyama. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Kazuhiko Osoda's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the field. His work not only addresses critical medical needs but also paves the way for future advancements in treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…